BioCentury
ARTICLE | Company News

ClinTrials, Inveresk Research Group Ltd. deal

February 26, 2001 8:00 AM UTC

Indigo Acquisition, a subsidiary of Inveresk, a CRO, will acquire CCRO for $6 per share, or $110.4 million based on CCRO's 18.4 million shares outstanding. ...